Literature DB >> 11189688

Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.

N K Simpson1, C C Johnson, S L Ogden, E Gamito, N Trocky, C McGuire, J Martin, S Barrow, L Lamerato, L M Flickinger, K G Broski, D Engelhard, C Hilke, J Bonk, B Gahagan, L H Gren, J Childs, K Lappe, M Fouad, J Thompson, D Sullivan.   

Abstract

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial has a total enrollment goal of almost 150,000 participants. These participants are being recruited at ten screening centers across the United States. All screening centers tested recruitment methodologies during a 1-year pilot phase. The main phase of recruitment was planned to take place over a 3-year period. The majority of participants are being recruited during the main phase of the study. Each of the screening centers tailors recruitment to its individual catchment area. Recruitment strategies in the PLCO trial are described. As the trial began, several protocol changes were made to help to increase enrollment. The National Cancer Institute (NCI) initiated recruitment efforts at the national level. The individual screening centers describe some of the specific recruitment experiences encountered. As the study progressed, the NCI implemented special initiatives to increase the enrollment of minority participants.

Entities:  

Mesh:

Year:  2000        PMID: 11189688     DOI: 10.1016/s0197-2456(00)00102-1

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  15 in total

1.  The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.

Authors:  Christine C Johnson; Bruce Kessel; Thomas L Riley; Lawrence R Ragard; Craig R Williams; Jian-Lun Xu; Saundra S Buys
Journal:  Gynecol Oncol       Date:  2008-06-30       Impact factor: 5.482

2.  Prostate-Specific Antigen Screening: Time to Change the Dominant Forces on the Pendulum.

Authors:  Jonathan E Shoag; Peter N Schlegel; Jim C Hu
Journal:  J Clin Oncol       Date:  2016-10-10       Impact factor: 44.544

3.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Authors:  Robert E Schoen; Paul F Pinsky; Joel L Weissfeld; Lance A Yokochi; Timothy Church; Adeyinka O Laiyemo; Robert Bresalier; Gerald L Andriole; Saundra S Buys; E David Crawford; Mona N Fouad; Claudine Isaacs; Christine C Johnson; Douglas J Reding; Barbara O'Brien; Danielle M Carrick; Patrick Wright; Thomas L Riley; Mark P Purdue; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok; Christine D Berg
Journal:  N Engl J Med       Date:  2012-05-21       Impact factor: 91.245

4.  Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Authors:  Joel L Weissfeld; Robert E Schoen; Paul F Pinsky; Robert S Bresalier; V Paul Doria-Rose; Adeyinka O Laiyemo; Timothy Church; Lance A Yokochi; Susan Yurgalevitch; Joshua Rathmell; Gerald L Andriole; Saundra Buys; E David Crawford; Mona Fouad; Claudine Isaacs; Lois Lamerato; Douglas Reding; Philip C Prorok; Christine D Berg
Journal:  J Natl Cancer Inst       Date:  2012-01-31       Impact factor: 13.506

5.  Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer.

Authors:  Felix Leung; Marcus Q Bernardini; Marshall D Brown; Yingye Zheng; Rafael Molina; Robert C Bast; Gerard Davis; Stefano Serra; Eleftherios P Diamandis; Vathany Kulasingam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07-22       Impact factor: 4.254

Review 6.  Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2015-05-01

Review 7.  How to get older people included in clinical studies.

Authors:  Miles D Witham; Marion E T McMurdo
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience.

Authors:  Electra D Paskett; Katherine W Reeves; John M McLaughlin; Mira L Katz; Ann Scheck McAlearney; Mack T Ruffin; Chanita Hughes Halbert; Cristina Merete; Faith Davis; Sarah Gehlert
Journal:  Contemp Clin Trials       Date:  2008-07-31       Impact factor: 2.226

9.  ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.

Authors:  Jingchun Chen; Darlene H Brunzell; Kia Jackson; Andrew van der Vaart; Jennie Z Ma; Thomas J Payne; Richard Sherva; Lindsay A Farrer; Pablo Gejman; Douglas F Levinson; Peter Holmans; Steven H Aggen; Imad Damaj; Po-Hsiu Kuo; Bradley T Webb; Raymond Anton; Henry R Kranzler; Joel Gelernter; Ming D Li; Kenneth S Kendler; Xiangning Chen
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

10.  Randomized controlled trial comparing telephone and mail follow-up for recruitment of participants into a clinical trial of colorectal cancer screening.

Authors:  Arthur D Wong; John Kirby; Gordon H Guyatt; Paul Moayyedi; Parag Vora; John J You
Journal:  Trials       Date:  2013-02-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.